Dementia with Lewy bodies, or DLB, is a progressive degenerative disease or syndrome of the brain. It shares symptoms — and sometimes overlaps — with several diseases, especially Alzheimer's and Parkinson's.
People who develop DLB have behavioral and memory symptoms of dementia, like those of Alzheimer's disease and, to varying extents, the physical, motor system symptoms seen in Parkinson's disease. But the mental symptoms of a person with DLB might fluctuate frequently, motor symptoms are milder than for Parkinson's, and DLB patients usually have vivid visual hallucinations.
Dementia with Lewy bodies is also called Lewy body dementia, diffuse Lewy body disease, Lewy body disease, cortical Lewy body disease, Lewy body variant of Alzheimer's disease or Parkinson's disease dementia. It is the second most common dementia, accounting for 20 percent of those with dementia (Alzheimer's disease is first). Dementia is a gradual, progressive decline in mental ability (cognition) that affects memory, thinking processes, behavior and physical activity. In addition to these mental symptoms, persons with DLB experience physical symptoms of parkinsonism, including mild tremor, muscle stiffness and movement problems. Strong visual hallucinations also occur.
DLB is named after smooth round protein lumps (alpha-synuclein) called Lewy bodies, that are found in the nerve cells of the affected parts of the brain. These abnormal protein structures were first described in 1912 by Dr. Frederich Heinrich Lewy, a contemporary of Dr. Alois Alzheimer, who first identified the more common form of dementia that bears his name.
Lewy bodies are found throughout the outer layer of the brain (the cerebral cortex) and deep inside the midbrain and brainstem. They are often found in those diagnosed with Alzheimer's, Parkinson's, Down syndrome and other disorders.
The cause of DLB is unknown and no specific risk factors are identified. Cases have appeared among families but there does not seem to be a strong tendency for inheriting the disease. Genetic research may reveal more information about causes and risk in the future. It usually occurs in older adults between the ages of 50 and 85, and slightly more men than women have the disease.
Caregiving and DLB
DLB patients can live at home with frequent reassessment and careful monitoring and supervision. Caregivers must watch the patient closely because of the tendency for them to fall or lose consciousness. Particular care should be taken when a patient is standing up from a chair or getting out of bed, as blood pressure can drop, causing the patient to lose his or her balance. Dementia prevents patients from learning new actions that might help them overcome movement problems, such as learning to use a walker. They may need more assistance some days than others, and can be reassured by a caregiver's help in turning attention away from the hallucinations.
Caregivers must learn to navigate both skills in dealing with cognitive, behavioral and motor disabilities. Attending support groups and learning skills in how to communicate with someone with dementia as well as learning skills in helping someone with a motor disorder will reduce caregiver stress and frustration.
Caregivers can turn to a California Caregiver Resource Center for assistance and to a qualified diagnostic center for initial diagnosis and follow up. In other states, resources can be found through local and state offices on aging and health, like your Area Agency on Aging or the Alzheimer's Association.
Initial symptoms of DLB usually are similar to those of Alzheimer's or vascular dementia and are cognitive in nature, like acute confusion, loss of memory, and poor judgment. Other patients may first show the neuromuscular symptoms of parkinsonism — loss of spontaneous movement, rigidity (muscles feel stiff and resist movement), and shuffling gait, while still others may have visual hallucinations as the first symptom. Patients may also suffer from delusions or depression.
Key symptoms are:
- Problems with short-term memory, like forgetting recent events.
- Brief episodes of unexplained confusion and other behavioral or cognitive problems. The individual may become disoriented to the time or location where he or she is, have trouble with speech, have difficulty finding words or following a conversation, experience visuospatial difficulty (for example, finding one's way), and have such problems in thinking as inattention, mental inflexibility, indecisiveness, lack of judgment, lack of initiative and loss of insight.
- Fluctuation in the occurrence of cognitive symptoms from moment to moment, hour to hour, day to day or week to week. For example, the person may converse normally one day and be mute and unable to speak the next day. There are also fluctuations in attention, alertness and wakefulness.
- Well defined, vivid, recurrent visual hallucinations. These hallucinations are well formed and detailed. In DLB's early stage, the person may even acknowledge and describe the hallucinations. They are generally benign and patients are not scared by them. Hallucinations may also be auditory (hearing sounds), olfactory (smelling or tasting something) or tactile (feeling or touching something that is not there).
- Movement problems of parkinsonism, sometimes referred to as extrapyramidal signs. These symptoms often seem to start spontaneously and may include flexed posture, shuffling gait, muscle jerks or twitches, reduced arm swing, loss of dexterity, limb stiffness, a tendency to fall, balance problems, bradykinesia (slowness of movement), tremor, shakiness and lack of facial expression.
- Rapid eye movement sleep behavior disorder. This is characterized by vivid dreaming, talking in one's sleep, and excessive movement while asleep, including occasionally hitting a bed partner. The result may be excessive daytime drowsiness and this symptom may appear years before DLB is diagnosed. About 50 percent of patients have this symptom.
Movement and motor problems occur in later stages for 70 percent of people with DLB. But for 30 percent of DLB patients, and more commonly those who are older, Parkinson's symptoms occur first, before dementia symptoms. In these individuals, cognitive decline tends to start with depression or mild forgetfulness.
Testing and diagnosis
Dementia with Lewy bodies is difficult to diagnose. Not only does it resemble other dementias, it overlaps with Alzheimer's, Parkinson's and other disorders, which may result in it being difficult to rule out or exclude. Because no single test exists to diagnose DLB, a variety of medical, neurological and neuropsychological tests are used to pinpoint it and its possible overlap with other illnesses. A definitive diagnosis can be made only by an autopsy at death. There are no medications approved to specifically treat DLB.
Although Lewy bodies are found in brains of patients with other diseases, and because testing will involve several approaches, it is useful to understand what happens to the brain of a person with DLB. Three significant changes or pathological features are seen in brains afflicted by DLB:
- The brain's cerebral cortex (outer layers of the brain) degenerates or shrinks. This can affect reasoning and complex thinking, understanding personality, movement, speech and language, sensory input and visual perceptions of space. Degeneration also occurs in the limbic cortex at the center of the brain, which plays a major role in emotions and behavior. Lewy bodies form throughout these degenerating cortical areas.
- Nerve cells die in the midbrain, especially in an area that also degenerates in Parkinson's disease, the substantia nigra, located in the brainstem. These cells are involved in making the neurotransmitter (brain messenger) dopamine. Lewy bodies are found in the nerve cells that remain. The midbrain is involved in memory formation and learning, attention and psychomotor (muscular movement) skills.
- Lesions called Lewy neuritis that affect nerve cell function are found in DLB brains, especially in the hippocampus, an area of the brain essential for forming new memories.
None of the symptoms of dementia with Lewy bodies is specific only to DLB. To address this problem, an international group of researchers and clinicians developed a set of diagnostic criteria in 1995, called the Consensus Guidelines that can reliably point to DLB:
Must be present:
- Progressive cognitive decline (decrease in thinking ability) that interferes with normal social or occupational activities. Memory problems do not necessarily occur in the early period but will occur as DLB progresses. Attention, language, understanding and reasoning, ability to do arithmetic, logical thinking and perceptions of space and time will be impaired.
Two of the following are present (one also indicates possibility of DLB):
- Fluctuating cognition and mental problems, vary during the day, especially attention and alertness.
- Visual hallucinations, detailed and well-formed visions occur and recur.
- Parkinsonism: motor related and movement problems appear.
A DLB diagnosis is even more likely if the patient also experiences repeated falls, fainting, brief loss of consciousness, delusions, or is sensitive to neuroleptic medications that are given to control hallucinations and other psychiatric symptoms.
Finally, the timing of symptoms is a reliable clue: if both mental and motor symptoms appear within one year of each other, DLB is more likely the cause. Signs of stroke or vascular dementia usually negate the likelihood of DLB.
Testing is usually done to rule out other possible causes of dementia. Brain imaging (CT scan or MR imaging) can detect brain shrinkage and help rule out stroke, fluid on the brain (normal pressure hydrocephalus), or subdural hematoma. Blood and other tests might show vitamin B-12 deficiency, thyroid problems, syphilis, HIV or vascular disease. Depression is also a common cause of dementia-like symptoms. Additional tests can include an electroencephalogram (EEG) or spinal tap. Scans using SPECT or PET technology have shown promise in detecting differences between DLB and Alzheimer's disease.
Alzheimer's and Parkinson's: Differences and overlap with DLB
DLB's similarity to Alzheimer's and Parkinson's diseases and the fact that Lewy bodies are often found in the brains of patients with these diseases means that clinicians must pay close attention to the factors that distinguish DLB:
- Memory and other cognitive problems occur in both DLB and Alzheimer's. But in DLB they fluctuate frequently.
- DLB patients experience more depression than do Alzheimer's patients.
- Hallucinations are experienced by Alzheimer's patients in late stages, and by Parkinson's patients who take medications to improve movement and tremor. In DLB, hallucinations occur in early stages, and they are frequent, vivid and detailed.
- Neuroleptic drugs (sometimes called psychotropic drugs) prescribed to lessen the so-called psychiatric symptoms of dementia, such as hallucinations, agitation or restlessness will induce Parkinson's in some DLB patients.
- Life expectancy is slightly shorter for DLB than for Alzheimer's patients.
- At autopsy the brains of DLB patients have senile plaques, a hallmark of Alzheimer's. Another Alzheimer's feature, neurofibrillary tangles, are absent or found in fewer numbers and are concentrated in the neocortex. Other Alzheimer's features — regional neuronal loss, spongiform change and synapse loss, neurochemical abnormalities and neurotransmitter deficits — are also seen. But DLB-afflicted brains are less damaged than are Alzheimer's brains.
- In DLB movement problems are spontaneous; the symptoms begin suddenly.
- Tremor is less pronounced in DLB than in Parkinson's. Also, DLB patients respond less dramatically to drugs, like as Levodopa, that are used to treat Parkinson's. Nerve cell loss in the subtantia nigra is not as severe in DLB. Both DLB and Parkinson's patients may sometimes experience fainting and wide alterations in blood pressure. Some Parkinson's patients develop dementia in later stages. Dementia is usually the presenting symptom in DLB.
- Parkinson's patients lose the neurotransmitter dopamine; Alzheimer's patients lose the neurotransmitter acetylcholine. DLB patients lose both.
- In DLB, Alzheimer-like and Parkinson-like symptoms appear within one year of each other.
Despite these differences, a diagnosis of dementia with Lewy bodies does not preclude a positive diagnosis of Alzheimer's, Parkinson's or other diseases common in older age.
Duration and treatment
With an average lifespan after onset of five to seven years, the progress of dementia with Lewy bodies is relentless, but the rate of decline varies with each person. DLB does not follow a pattern of stages as is seen in some other dementias. Death usually occurs from pneumonia or other illness. There is neither cure nor specific treatment to arrest the course of the disease.
Caution must be used in treating a person with DLB. Medications must be monitored closely for proper balance because some patients are adversely affected by some drugs. Neuroleptic (tranquilizing) anti-psychotic medications, like haloperidol (Haldol) or thioridazine (Mellaril), as well as benzodiazepines (Valium, Ativan) and anti-histamines can cause extreme adverse reactions in DLB patients. Side effects include motor related symptoms, catatonia (non-responsiveness), loss of cognitive function and/or development of muscle rigidity. These medications are sometimes used in Alzheimer's patients to help with hallucinations and behavioral symptoms, but should not be used in patients with DLB.
Levodopa may be given to treat the parkinsonism, however, it may increase the hallucinations of DLB patients and aggravate other symptoms, like cognitive functioning. It is less effective in treating tremor in DLB patients than in Parkinson's patients. Aricept or other cholinesterase inhibitors are given to treat the hallucinations. Some anti-depressants have shown positive results, while others are contraindicated.
When considering surgery, families should meet with the anesthesiologist to discuss possible side effects of anesthesia, as DLB patients are prone to delusions and a decline in motor functioning after anesthesia.
Next Avenue Editors Also Recommend:
Next Avenue is bringing you stories that are not only motivating and inspiring but are also changing lives. We know that because we hear it from our readers every single day. One reader says,
"Every time I read a post, I feel like I'm able to take a single, clear lesson away from it, which is why I think it's so great."
Your generous donation will help us continue to bring you the information you care about. What story will you help make possible?
© Family Caregiver Alliance. All rights reserved.